跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AJEMNYE ustekinumab 45 mg / 0.5 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
AJEMNYE ustekinumab 45 mg / 0.5 mL solution for injection vial
Approved
STANDARD
AJEMNYE ustekinumab 45 mg / 0.5 mL solution for injection vial
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
3faff66b743dfff2
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
3faff66b743dfff2
Product Name
AJEMNYE ustekinumab 45 mg / 0.5 mL solution for injection vial
Artg Id
441423
Artg Name
AJEMNYE ustekinumab 45 mg / 0.5 mL solution for subcutaneous injection vial
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2024-05-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
3faff66b743dfff2
Type
Standard
Back to TGA Approvals